Antimicrobial in vitro activities of ceftazidime-avibactam, meropenem-vaborbactam and plazomicin against multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa - a pilot Bulgarian study

被引：17
|
作者：
Savov, Encho [1 ]
Trifonova, Angelina [1 ]
Kovachka, Krassimira [2 ]
Kjosseva, Elena [1 ]
Strateva, Tanya [3 ]
机构：
[1] Mil Med Acad, Dept Mil Epidemiol & Hyg, Microbiol Lab, Sofia, Bulgaria
[2] Multiprofile Hosp Act Treatment, Samokov, Bulgaria
[3] Med Univ Sofia, Fac Med, Dept Med Microbiol, Sofia, Bulgaria
来源：
INFECTIOUS DISEASES | 2019年 / 51卷 / 11-12期
关键词：
GRAM-NEGATIVE BACTERIA; INFECTIONS;
D O I：
10.1080/23744235.2019.1653491
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：870 / 873
页数：4
相关论文
共 50 条
  • [1] Comparative In Vitro Activity of Ceftazidime-Avibactam, Imipenem-Relebactam, and Meropenem-Vaborbactam against Carbapenem-Resistant Clinical Isolates of Klebsiella pneumoniae and Pseudomonas aeruginosa
    Sophonsri, Anthony
    Kalu, Michelle
    Wong-Beringer, Annie
    ANTIBIOTICS-BASEL, 2024, 13 (05):
  • [2] In vitro activities of ceftazidime/avibactam alone or in combination with antibiotics against multidrug-resistant Acinetobacter baumannii isolates
    Kara, Emel Mataraci
    Yilmaz, Mesut
    Celik, Berna Ozbek
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2019, 17 : 137 - 141
  • [3] Ceftazidime-avibactam, meropenem-vaborbactam, and imipenem-relebactam activities against multidrug-resistant Enterobacterales from United States Medical Centers (2018-2022)
    Sader, Helio S.
    Mendes, Rodrigo E.
    Duncan, Leonard
    Kimbrough, John H.
    Carvalhaes, Cecilia G.
    Castanheira, Mariana
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2023, 106 (03)
  • [4] CEFTAZIDIME-AVIBACTAM AND AZTREONAM AGAINST MULTIDRUG- RESISTANT PSEUDOMONAS AERUGINOSA
    Toor, Rebecca
    Garcia, Esther
    CRITICAL CARE MEDICINE, 2020, 48
  • [5] In vitro susceptibility of carbapenem resistant Enterobacterales to meropenem-vaborbactam and ceftazidime-avibactam at a single academic medical centre
    Adams, Jenna
    Santarossa, Maressa
    Harrington, Amanda
    Bauer, Michael
    Wozniak, Amy
    Labuszewski, Laurie
    Albarillo, Fritzie S. S.
    INFECTIOUS DISEASES, 2023, 55 (04) : 282 - 291
  • [6] Ceftazidime-Avibactam in Combination With Fosfomycin: A Novel Therapeutic Strategy Against Multidrug-Resistant Pseudomonas aeruginosa
    Papp-Wallace, Krisztina M.
    Zeiser, Elise T.
    Becka, Scott A.
    Park, Steven
    Wilson, Brigid M.
    Winkler, Marisa L.
    D'Souza, Roshan
    Singh, Indresh
    Sutton, Granger
    Fouts, Derrick E.
    Chen, Liang
    Kreiswirth, Barry N.
    Ellis-Grosse, Evelyn J.
    Drusano, George L.
    Perlin, David S.
    Bonomo, Robert A.
    JOURNAL OF INFECTIOUS DISEASES, 2019, 220 (04): : 666 - 676
  • [7] In vitro activity of imipenem-relebactam against KPC-producing Klebsiella pneumoniae resistant to ceftazidime-avibactam and/or meropenem-vaborbactam
    Lombardo, Donatella
    Ambretti, Simone
    Lazzarotto, Tiziana
    Gaibani, Paolo
    CLINICAL MICROBIOLOGY AND INFECTION, 2022, 28 (05) : 749 - 751
  • [8] Activity of Meropenem-Vaborbactam against Pseudomonas aeruginosa and Acinetobacter baumannii in a Neutropenic Mouse Thigh Infection Model
    Sabet, Mojgan
    Tarazi, Ziad
    Griffith, David C.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (01)
  • [9] In vitro Apramycin Activity against multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa
    Kang, Anthony D.
    Smith, Kenneth P.
    Eliopoulos, George M.
    Berg, Anders H.
    Mccoy, Christopher
    Kirby, James E.
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2017, 88 (02) : 188 - 191
  • [10] Successful ceftazidime-avibactam therapy in a patient with multidrug-resistant Pseudomonas aeruginosa infective endocarditis
    Lima, Olalla
    Sousa, Adrian
    Filgueira, Anton
    Otero, Anton
    Cabaleiro, Andrea
    Martinez-Lamas, Lucia
    Vasallo, Francisco
    Perez-Rodriguez, M. Teresa
    INFECTION, 2022, 50 (04) : 1039 - 1041
12345